206 related articles for article (PubMed ID: 16715661)
1. Retrospective review: usefulness of a number of imaging modalities including CT, MRI, technetium-99m pertechnetate scintigraphy, gallium-67 scintigraphy and F-18-FDG PET in the differentiation of benign from malignant parotid masses.
Ozawa N; Okamura T; Koyama K; Nakayama K; Kawabe J; Shiomi S; Yamane H; Inoue Y
Radiat Med; 2006 Jan; 24(1):41-9. PubMed ID: 16715661
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors.
Uchida Y; Minoshima S; Kawata T; Motoori K; Nakano K; Kazama T; Uno T; Okamoto Y; Ito H
Clin Nucl Med; 2005 Mar; 30(3):170-6. PubMed ID: 15722820
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions.
Okamura T; Kawabe J; Koyama K; Ochi H; Yamada R; Sakamoto H; Matsuda M; Ohashi Y; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():209-13. PubMed ID: 9879423
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of technetium-99m-pertechnetate scintigraphy with lemon juice stimulation to evaluate Warthin's tumor.
Murata Y; Yamada I; Umehara I; Okada N; Shibuya H
J Nucl Med; 1998 Jan; 39(1):43-6. PubMed ID: 9443737
[TBL] [Abstract][Full Text] [Related]
5. Warthin's tumor of parotid gland on Tc-99m pertechnetate scintigraphy with lemon juice stimulation: Tc-99m uptake, size, and pathologic correlation.
Miyake H; Matsumoto A; Hori Y; Takeoka H; Kiyosue H; Hori Y; Mori H; Ueyama S; Kashima K
Eur Radiol; 2001; 11(12):2472-8. PubMed ID: 11734943
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Four cases of Warthin's tumor of the parotid gland detected with FDG PET.
Horiuchi M; Yasuda S; Shohtsu A; Ide M
Ann Nucl Med; 1998 Feb; 12(1):47-50. PubMed ID: 9559962
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of RI scintiscanning to parotid gland tumors].
Shinohara S; Yamamoto E; Tanabe M; Maetani T; Fujiwara K; Kim T
Nihon Jibiinkoka Gakkai Kaiho; 2001 Sep; 104(9):852-8. PubMed ID: 11605225
[TBL] [Abstract][Full Text] [Related]
9. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
[TBL] [Abstract][Full Text] [Related]
10. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
[TBL] [Abstract][Full Text] [Related]
11. Does 18F-FDG PET/CT play a role in the differential diagnosis of parotid masses.
Rubello D; Nanni C; Castellucci P; Rampin L; Farsad M; Franchi R; Mariani G; Menaldo G; Fanti S
Panminerva Med; 2005 Sep; 47(3):187-9. PubMed ID: 16462726
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomographic imaging of pleomorphic adenoma in the parotid gland.
Matsuda M; Sakamoto H; Okamura T; Nakai Y; Ohashi Y; Kawabe J; Ochi H; Wakasa K
Acta Otolaryngol Suppl; 1998; 538():214-20. PubMed ID: 9879424
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ⁶⁸Ga-DOTATATE PET-CT, ¹⁸F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma.
Ozkan ZG; Kuyumcu S; Uzum AK; Gecer MF; Ozel S; Aral F; Adalet I
Nucl Med Commun; 2015 Mar; 36(3):242-50. PubMed ID: 25369749
[TBL] [Abstract][Full Text] [Related]
15. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of conventional whole-body ¹⁸F-FDG PET/CT in the incidental findings of parotid masses.
Wang HC; Zuo CT; Hua FC; Huang ZM; Tan HB; Zhao J; Guan YH
Ann Nucl Med; 2010 Oct; 24(8):571-7. PubMed ID: 20640540
[TBL] [Abstract][Full Text] [Related]
17. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
19. [18F-FDG PET/CT and 99mTc-MIBI scintigraphy in evaluation of patients with multiple myeloma and monoclonal gammopathy of unknown significance: comparison of methods].
Myslivecek M; Bacovský J; Scudla V; Koranda P; Minarík J; Buriánková E; Formánek R; Zapletalová J
Klin Onkol; 2010; 23(5):325-31. PubMed ID: 21061682
[TBL] [Abstract][Full Text] [Related]
20. Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results.
Karaman CZ; Tanyeri A; Özgür R; Öztürk VS
Dentomaxillofac Radiol; 2021 May; 50(4):20200391. PubMed ID: 33237812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
